A Phase II Open-label Pilot Study Evaluating the Maintenance Therapy With Exemestane Plus Everolimus After Induction Chemotherapy in Patients With Hormone-receptor Positive Metastatic Breast Cancer
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Everolimus (Primary) ; Exemestane (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- 29 Jan 2014 New trial record